nabu.science
MethodologyAboutContact

 

Reliability concern: This paper was retracted on 2023-06-21. See notice: 10.1155/2023/9787956.

  • Snapshot
  • Key Claims
  • Strengths & Limitations
  • Commentary
  • From the Authors
  • Author Note / Field Feedback
  • Dimension breakdown
  • Impact Profile
Free · About 5 minutes
Report #NBU-C07E0B37·Framework v5.0·Pipeline v0.4·Evaluated 01 Jun 2026·OECD: 3.2 Clinical medicine·Subfield: Radiology, Nuclear Medicine and Imaging·Basis: Full text·Type: Diagnostic accuracy study

Application Value of Mathematical Models of Diffusion-Weighted Magnetic Resonance Imaging in Differentiating Breast Cancer Lesions.

Jiang et al.Jiang, Chen, Liu et al.·2021·Evidence-based complementary and alternative medicine : eCAM·10.1155/2021/1481271 ↗

In brief

A clinically relevant DWI model comparison in breast imaging whose contradictory statistical reporting and missing diagnostic accuracy metrics undermine its core conclusions.

ReliabilityConcerns4 of 4 checks completeRead the 3 entries ↓
Abstract

OBJECTIVE: To determine the application value of the mono-exponential model, dual-exponential model, and stretched-exponential model of MRI with diffusion-weighted imaging (DWI) in breast cancer (BC) lesions.

METHODS: Totally 64 cases with BC admitted to our hospital between June 2019 and October 2020 were enrolled in this study. They had 71 lesions in total, including 40 benign tumor lesions (including 9 breast cyst lesions) and 31 malignant tumor lesions. After DWI examination, with normal glands as control, mono-exponential model (ADC) map, dual-exponential model (Standard-ADC) map, slow apparent diffusion coefficient (Slow-ADC) map, fast-apparent diffusion coefficient (Fast-ADC) map, and stretched-exponential model (DDC) map were processed, and corresponding values were generated. Then, the situation and significance of each parameter in breast cysts, benign breast tumor lesions, and malignant tumor lesions were analyzed.

RESULTS: The values of ADC, Standard-ADC, and DDC of breast cysts were higher than those of normal glands (all P < 0.05), and the values of ADC and DDC of benign breast tumor lesions were lower than those of normal glands (P < 0.05). In addition, malignant breast tumor lesions had lower values of ADC, Standard-ADC, Slow-ADC, and DDC and a higher Fast-ADC value compared to normal glands (all P < 0.05). Compared with benign tumor lesions, malignant tumor lesions had lower values of ADC, Standard-ADC, Slow-ADC, and DDC and a higher value of Fast-ADC (all P < 0.05). Moreover, the receiver operating characteristic (ROC) curve-based analysis revealed that all the above models could be adopted to effectively evaluate the deterioration of benign breast tumor lesions (all P < 0.05), and DDC value had the most significant diagnostic effect on malignant tumor lesions (P < 0.05).

CONCLUSION: Both dual-exponential model and stretched-exponential model of DWI can help effectively evaluate the progression of benign breast tumors, and the stretched-exponential model is more effective in the diagnosis of malignant breast tumors. These models are of great help to the future clinical diagnosis of BC.

Strengths · Limitations

Strengths

#contribution

Clinically relevant diagnostic question addressed

The study targets a genuine clinical need — non-invasive differentiation of benign from malignant breast lesions — comparing three DWI mathematical models that are of active interest in breast radiology.

↳ Introduction; Abstract Objective

#methodological rigour

Detailed MRI acquisition protocol reported

The methods section provides specific parameters for MR plain scan, single b-value DWI, multi-b-value DWI (12 b-values specified), and dynamic contrast-enhanced MR, enabling replication of the imaging protocol.

↳ Methods Section 2.2

#contribution

Systematic comparison across lesion types

The study systematically compares DWI parameters across breast cysts, benign tumours, and malignant tumours against normal gland tissue, and reports ROC-based diagnostic performance for each lesion category.

↳ Results Sections 3.1–3.8

Limitations

#methodological rigour

Self-contradictory statistical reporting in results

Sections 3.1 and 3.3 simultaneously describe DWI parameters as 'not different from those of normal glands' and as having 'statistically significant' differences (P < 0.05). This logical contradiction makes it impossible to determine the actual findings for several key parameters.

↳ Results Sections 3.1, 3.3

#methodological rigour

Missing AUC values and incomplete ROC reporting

No AUC values, confidence intervals, or decision thresholds are reported for any of the ROC analyses across Sections 3.2, 3.4, 3.6, and 3.8. Without AUC values, the central claim that DDC has the 'most significant diagnostic effect' cannot be evaluated or verified.

↳ Results Sections 3.2, 3.4, 3.6, 3.8

#methodological rigour

No multiple comparison correction applied

Approximately 40+ independent-samples T-tests are conducted across five DWI parameters and multiple lesion type comparisons with no correction for multiple comparisons, leaving the false discovery rate uncontrolled at the P < 0.05 threshold.

↳ Methods Section 2.3; Results Sections 3.1–3.7

Does this match your read? Add your assessment ↓

Withdrawn — shown for reference only

Nabu Commentary

This diagnostic accuracy study asks whether advanced DWI models improve breast lesion differentiation, a question of genuine clinical interest. The imaging protocol is documented with adequate specificity, and the systematic comparison across lesion types represents a reasonable study design. However, execution is substantially undermined by three interrelated deficiencies. First, the contradictory statements in Results Sections 3.1 and 3.3 — where parameters are described as both 'not different' and 'statistically significant' — create genuine ambiguity about which parameters actually discriminate lesion types from normal tissue. Second, the complete absence of AUC values from all ROC analyses means the paper's central diagnostic performance claims cannot be independently evaluated, and the conclusion that DDC outperforms other models rests on informal comparison of sensitivity-specificity pairs rather than formal statistical testing. Third, the thin literature engagement — with only two background references in the introduction and no discussion of prior IVIM or stretched-exponential DWI studies in breast cancer — leaves the paper's contribution poorly contextualised within an already substantial evidence base.

Evaluate another paper

Free · About 5 minutes · Research preview

Author Note / Field Feedback

Nabu’s assessment, alongside the field’s view.

Are you an author of this paper?

Dimension breakdown

Evidence Score

Out of 5
012345
2.4±0.2

Contribution
2.6

The study addresses a legitimate clinical question — whether advanced DWI models outperform the standard mono-exponential model for breast lesion differentiation. However, the contribution is incremental given extensive prior literature on IVIM and stretched-exponential DWI in breast cancer, and the claim of novelty ('found for the first time') in the Discussion is an overclaim unsupported by the cited literature.

Discussion Section 4; Abstract

we found for the first time that the ADC value of breast cyst increased

Methodological Rigour
2.2

The study design is appropriate in principle but execution has significant gaps: no correction for multiple comparisons across approximately 40+ hypothesis tests, no AUC values or confidence intervals for ROC analyses, no inter-reader reliability assessment for ROI placement, and an unexplained 'repeated three times and then averaged' analytical procedure. The contradictory statistical reporting in Sections 3.1 and 3.3 further undermines methodological credibility.

Sections 2.3, 3.1, 3.3, 3.2, 3.4, 3.6, 3.8

All calculations were repeated three times and then averaged

Reporting
2.7

The paper follows a logical structure from introduction through results to discussion, and MRI acquisition parameters are clearly reported. However, the contradictory sentences describing parameters as 'not different' yet 'statistically significant (P < 0.05)' in Results Sections 3.1 and 3.3 create genuine ambiguity about the actual findings for several key parameters.

Results Sections 3.1, 3.3; Methods Section 2.2

were not different from those of normal glands, and the differences were statistically significant

Positioning
2.3

The literature review is thin, with only two references cited in the introduction for the entire background and no substantive engagement with prior comparative studies of these specific DWI models in breast imaging. The Discussion does not cite existing studies using these models and does not reference STARD guidelines for diagnostic accuracy reporting.

Introduction; Discussion Section 4

Reliability

Concerns4 of 4 checks


Internal CoherenceConcern

Multiple instances of logically contradictory statistical reporting appear in the results sections, where parameters described as 'not different' from normal glands are simultaneously reported as having 'statistically significant' differences (P < 0.05). This pattern recurs across Sections 3.1, 3.3, and potentially 3.5, suggesting systematic misreporting rather than isolated error.

Research ConductNoted

Ethics approval and informed consent are declared but unverifiable: no committee name or approval identifier is provided. No conflicts of interest statement is present. Data availability is claimed only upon request with no repository or persistent identifier.

Flags: 2 declared / 5 total

Reference IntegrityClean

All 26 cited references resolved to real publications via PubMed, Crossref, or OpenAlex.

References not verified automatically are resolved manually within 24 hours.

Post-Publication RecordConcern

This paper was retracted on 2023-06-21. See notice: 10.1155/2023/9787956.

Last checked: 17 Oct 2026

Sources: Crossref (incl. Retraction Watch) ✓

Impact Profile

Impact areaHealth · Cancer and neoplasms · Breast cancer
Type of advanceEmpirical
Route to useSuggested
AdvanceExtends
BeneficiariesLarge
CitationsFWCI 0.3
Policy · patentNot yet traced
ReachedNot reachedNot assessable or unverified
ReadinessPiloted
Foundational
Controlled
Piloted
Validated
Implementable
FoundationalImplementable

The diagnostic performance of the models was demonstrated once in a small single-hospital cohort of 64 patients with no independent validation.

From the paper
“These models are of great help to the future clinical diagnosis of BC.”

The paper names clinical diagnosis of breast cancer as a real-world use of its findings but never specifies which clinicians, services or settings would apply them.

Pathway

Radiologists could adopt stretched-exponential DDC maps from multi-b-value DWI as a non-invasive adjunct to help distinguish benign from malignant breast lesions before biopsy.

Barrier

The single-centre sample of 64 patients with no external validation, and only moderate sensitivity and specificity, leaves biopsy as the gold standard before clinical adoption.

Evaluated 13 Nov 2026 · GBD 2023 · glm_v1_3_3 · impact_profile_v1_3_3

Report an issue →

AI-generated, human-governed. Something look off? Contact us to request a review.

Keep reading

Related evaluations

Other papers Nabu has evaluated blind, starting with the same field.

  1. How Does Diagnostic Accuracy Evolve with Increased Breast MRI Experience?

    Wu, Alikhassi, Curpen · 2023 · Clinical medicine

    Primary claim

    Diagnostic accuracy improved exponentially with increased MRI experience (definition B, OR of 1.27 and 1.61 for 5 and 10 years, respectively, p = 0.03 for both).

    Tentative
    Evidence Score
    2.3±0.1
    Reliability
    Caveats
  2. General cognitive function and the brain's structural connectome

    Buchanan, Moodie, Batziou, et al. · 2026 · Basic medicine

    Primary claim

    g is supported by a widely distributed white matter network whose macroscopic wiring capacity, microstructural organisation, and age sensitivity contribute in distinct ways.

    Tentative
    Evidence Score
    3.6±0.2
    Reliability
    Caveats
  3. The Dementias Platform UK PET/MR harmonisation and test-retest study: assessment of PET repeatability and reproducibility across the national network

    Markiewicz, Thompson, Wardlaw, et al. · 2026 · Clinical medicine

    Primary claim

    CL values across 74 scans showed excellent test-retest agreement (ICC = 0.968), improving to 0.987 after exclusion of one attenuation correction related outlier.

    Supported
    Evidence Score
    3.3±0.2
    Reliability
    Caveats

How the rubric works →